Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer
CanariaBio Inc.
CanariaBio Inc.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Shanghai Hengrui Pharmaceutical Co., Ltd.
St. Petersburg State Pavlov Medical University
Peking Union Medical College Hospital
Jiangsu Cancer Institute & Hospital
Zhejiang Cancer Hospital
OHSU Knight Cancer Institute
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Leiden University Medical Center
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Samsung Medical Center
ChineseAMS
Swedish Medical Center
National University Hospital, Singapore
All India Institute of Medical Sciences
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Tehran University of Medical Sciences
Myrexis Inc.
Charite University, Berlin, Germany